-
1 Comment
Jiangsu Sihuan Bioengineering Co., Ltd is currently in a long term downtrend where the price is trading 18.6% below its 200 day moving average.
From a valuation standpoint, the stock is 14.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Jiangsu Sihuan Bioengineering Co., Ltd's total revenue rose by 5.4% to $118M since the same quarter in the previous year.
Its net income has dropped by 18.0% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 22.4% to $12M since the same quarter in the previous year.
Based on the above factors, Jiangsu Sihuan Bioengineering Co., Ltd gets an overall score of 3/5.
| ISIN | CNE0000001P8 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | SHE |
| CurrencyCode | CNY |
| Beta | 0.26 |
|---|---|
| Market Cap | 3B |
| Target Price | None |
| PE Ratio | None |
| Dividend Yield | None |
Jiangsu Sihuan Bioengineering Co., Ltd., together with its subsidiaries, engages in the production and sales of biopharmaceutical products in China and internationally. The company offers Delusen and New Delusen, a human interleukin-2 for injection are immunomodulators used for the biotherapy of tumors and treatment of patients with weakened immune function; Xinlisheng, a human granulocyte colony-stimulating factor injection used to treat neutropenia caused by bone marrow transplantation, cancer chemotherapy, myelodysplastic syndrome, and aplastic anemia; and Huanerbo, a human erythropoietin injection used to treat symptoms, such as anemia caused by renal insufficiency. It is also involved in the provision of flower planting; forest and natural ecosystem management and protection; forest improvement; forestry product sales; Chinese herbal medicine planting; landscaping project construction; urban municipal greening management; scenic area management; municipal facilities management; earthwork construction; engineering management services; forest park management and design management; external contracting; project cost consulting services; and sale of metal material, agricultural and sideline product, and building and decoration material. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000518.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
